新晨科技(300542.SZ)股东蒋琳华拟减持不超2.98%股份
格隆汇12月31日丨新晨科技(300542.SZ)公布,持公司股份2741.25万股(占公司剔除已回购股份后总股本比例11.93%)的股东蒋琳华计划以集中竞价方式、大宗交易方式减持公司股份不超过约685.31万股(占公司剔除已回购股份后总股本比例不超过2.98%),其中通过集中竞价方式减持股份的,自公告披露之日起十五个交易日后六个月内进行,且在任意连续九十个自然日内,减持股份的总数合计不得超过公司剔除已回购股份后总股本比例的1%;通过大宗交易方式减持股份的,自公告披露之日起三个交易日后六个月内进行,且在任意连续九十个自然日内,减持股份的总数合计不得超过公司剔除已回购股份后总股本比例的2%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.